![]() |
市場調查報告書
商品編碼
1699337
感染控制個人防護設備市場機會、成長動力、產業趨勢分析及 2025-2034 年預測Personal Protective Equipment for Infection Control Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 |
2024 年全球個人防護設備感染控制市場價值為 210 億美元,預計 2025 年至 2034 年期間的複合年成長率為 3.7%。個人防護設備在減少傳染病傳播方面發揮關鍵作用,尤其是在醫院、實驗室、診所和工業工作場所等高風險環境中。包括 COVID-19 和流感在內的傳染病日益流行,推動了對防護設備的持續需求。此外,抗菌紡織品和人體工學特性的進步提高了 PPE 的舒適性和功能性,促進了市場成長。
2023 年市場價值為 217 億美元,其中手部和手臂防護設備成為主導領域,佔 2024 年收入的 45.2%。醫療相關感染 (HAI) 病例的增加增加了對有效防護裝備的需求,特別是具有增強耐用性、觸覺靈敏度和耐化學性的手套。由於人們對 PPE 材料的認知不斷提高以及技術不斷進步,預計該領域在預測期內將經歷顯著擴張。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 210億美元 |
預測值 | 294億美元 |
複合年成長率 | 3.7% |
市場分為一次性 PPE 和可重複使用 PPE,其中一次性 PPE 市場領先,2024 年市場規模達 162 億美元。由於 CDC 和 WHO 等組織的嚴格監管建議,一次性 PPE 仍然是醫療機構的首選。醫療保健基礎設施的不斷擴張進一步刺激了需求,增強了對感染控制用品的必要性。預計減少交叉污染和提高衛生標準的日益重視將推動該領域的成長。
按最終用途分類,醫院佔據了最大的市場佔有率,2024 年創造了 126 億美元的收入。醫院優先投資個人防護裝備 (PPE),以保護醫護人員和病患免受傳染威脅。感染控制措施,包括個人防護裝備的使用,對於降低醫療機構內疾病傳播的風險至關重要。外科手術和醫療程序的不斷增加也增加了對高品質防護設備的需求。由於醫療保健提供者繼續優先考慮安全性和遵守感染控制協議,預計該領域將在整個預測期內保持穩定成長。
在美國,2024 年感染控制 PPE 市場價值為 88 億美元,預計到 2034 年將達到 120 億美元。該國透過 OSHA、CDC 和 FDA 實施嚴格的感染控制政策,確保在醫療保健環境中遵守 PPE 指南。院內感染發生率的上升進一步推動了對感染控制產品的需求,預計到 2032 年,對這些產品的需求將達到 630 億美元。強而有力的監管框架,加上對醫療保健安全的重視,將使美國市場在未來幾年保持持續成長。
The Global Personal Protective Equipment For Infection Control Market was valued at USD 21 billion in 2024 and is expected to grow at a 3.7% CAGR from 2025 to 2034. PPE plays a critical role in minimizing the spread of infectious diseases, especially in high-risk settings such as hospitals, laboratories, clinics, and industrial workplaces. The continuous demand for protective equipment is driven by the increasing prevalence of infectious diseases, including COVID-19 and influenza. Additionally, advancements in antimicrobial textiles and ergonomic features have enhanced the comfort and functionality of PPE, contributing to market growth.
With the market valued at USD 21.7 billion in 2023, hand and arm protection equipment emerged as the dominant segment, accounting for 45.2% of revenue in 2024. The increasing cases of healthcare-associated infections (HAIs) have heightened the need for effective protective gear, particularly gloves with enhanced durability, tactile sensitivity, and chemical resistance. The segment is anticipated to experience significant expansion over the forecast period due to growing awareness and technological improvements in PPE materials.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $21 Billion |
Forecast Value | $29.4 Billion |
CAGR | 3.7% |
The market is divided into disposable and reusable PPE, with the disposable segment leading at USD 16.2 billion in 2024. Disposable PPE remains a preferred choice in healthcare facilities due to strict regulatory recommendations from organizations such as the CDC and WHO. The demand is further fueled by the continuous expansion of healthcare infrastructure, reinforcing the necessity for infection control supplies. The growing emphasis on reducing cross-contamination and improving hygiene standards is expected to drive the segment's growth.
By end use, hospitals captured the largest market share, generating USD 12.6 billion in revenue in 2024. Hospitals prioritize investment in PPE to safeguard healthcare workers and patients from infectious threats. Infection control measures, including PPE usage, are crucial for reducing the risk of disease transmission in medical facilities. The rising number of surgical and medical procedures also amplifies the demand for high-quality protective equipment. The segment is expected to maintain steady growth throughout the forecast period as healthcare providers continue to prioritize safety and compliance with infection control protocols.
In the United States, the PPE for infection control market was valued at USD 8.8 billion in 2024 and is projected to reach USD 12 billion by 2034. The country enforces strict infection control policies through OSHA, the CDC, and the FDA, ensuring adherence to PPE guidelines in healthcare environments. The rising incidence of HAIs further drives the need for infection control products, with demand for these supplies expected to reach USD 63 billion by 2032. The strong regulatory framework, coupled with the emphasis on healthcare safety, positions the US market for consistent growth in the coming years.